All true.The insanity continues as another article today said expect the drop to continue into the 20’s. This is really pathetic. But our stellar Board will award AB another $30 million payout because”this is what the market dictates.” The market dictates we need to bring in a proven experienced leader from the outside that can drive growth and shareholder value. Until then please ask AB to stop sending the field any messages. He’s truly uninspiring to everyone but his children and financial advisor.
another person you wonder how he has kept his job this long given few results, DolstonTake a look at the CNBC article this morning on the Pfizer weight loss candidate. BID and mid stage study results showed around 6% loss of body weight in diabetics. Analysts say the phase two data needs to show weight reduction in mid teens. Dolsten soft pedals the product saying that dosing studies could lessen the GI side effects that “have been seen as limiting” and QD dosing trial is “within reach” next year. Not promising outlooks for a market where we plan to capture around 15% of the share and $10B.
Think anybody on the board reads Forbes? Here’s a few excerpts highlighting the sorry state of affairs. What company has EVER booked billions in unforecasted sales and still ends up losing value? The board may be Woke but they need to WAKE UP and fix this disaster or sell the entire mess
“Pfizer Stock Hits 3-Year Low—Down 50% From 2021 Peak
TOPLINE Pfizer shares tumbled again Monday, continuing the pharmaceutical giant’s struggles tied to declining demand for its Covid-19 products and essentially wiping out the entirety of the firm’s peak pandemic gains.
Pfizer stock slipped 1.6% to $28.96, closing at its lowest share price since March 26, 2020.
Excluding March 2020, when the stock market briefly crashed amid stay-at-home orders, Pfizer is now at its lowest share price since December 2016.
Pfizer shares are down more than 50% since their December 2021 peak of $57, with the stock crash coinciding with a significant decline in sales for its Paxlovid oral Covid treatment and its Covid vaccine.
BIG NUMBER
$170 billion. That’s how much market capitalization Pfizer has lost since December 2021.
KEY BACKGROUND
Including dividends, Pfizer has posted a -40% return on investment this year, the 15th-steepest loss of any S&P 500 company.
Pfizer, which was more valuable than both Eli Lilly and Novo Nordisk at the end of 2021, is now worth less than half of each firm.”
Amazing that anyone in a senior leadership position keeps their job amid this free fall. In "most" professional industries, this kind of performance gets a person fired and walked out the door.
The board needs to step up and do something. This won't happen because the board is "in on the game", and being financially rewarded for their position on the board. A company cannot thrive on empty slogans, or fluffy initiatives that don't drive revenue (those are just head fakes, diversions from the real issues). And when the answer is to just keep cutting and laying off? That's a very simple, low grade approach to a much bigger, systematic problem (that Wall Street isn't responding to).
If his priorities are inclusion and exclusion then he needs to be replaced immediately. The company is falling apart around his ears.But AB is going to some CEO conference to lecture them about inclusion and exclusion. First, how can any other CEO take this bozo seriously? They should look at his performance and similarly reduce their attention to his drivel by the same 50% as our stock price. Secondly, the board should compel him to stay in his lane, run the damn business and return something positive to shareholders.
Pfizer has always considered layoffs to be a way of returning value to stockholders- he is doing that.But AB is going to some CEO conference to lecture them about inclusion and exclusion. First, how can any other CEO take this bozo seriously? They should look at his performance and similarly reduce their attention to his drivel by the same 50% as our stock price. Secondly, the board should compel him to stay in his lane, run the damn business and return something positive to shareholders.
Sometimes it is a necessary step.Pfizer has always considered layoffs to be a way of returning value to stockholders- he is doing that.
But AB is going to some CEO conference to lecture them about inclusion and exclusion. First, how can any other CEO take this bozo seriously? They should look at his performance and similarly reduce their attention to his drivel by the same 50% as our stock price. Secondly, the board should compel him to stay in his lane, run the damn business and return something positive to shareholders.
It's probably very appropriate that this is his presentation. It certainly isn't going to be a session on "Maximizing Financial Gain on Covid Windfall Profits." The first question from the CEO's in the room should be "What tangible financial benefit has the company realized from this initiative?" The second question should be "The company set all-time highs in several financial categories in 2022, help us understand how, after a record financial year, the market cap and stock price are where they currently are?"
Why are you shocked? Pfizer never paid on Viagra back in the day because they said Leno was selling it on late night. We all laughed like hell at the militant and miserable reps. I guess things are still the same. The most unethical company in the industry
We may be ahead of schedule, how bout $25 by ‘24!"25 by 25" is coming true. $25 by 2025.
To be truthful here, there is a significant amount of fat. Do we really need all of these KAMs, each one making about as much as a Pediatrician or FP? How about out here in the field, where access in many areas is so bad many of us just mail it in (outside of lunches). I'll bet reps that cover major teaching hospitals in the Northeast, Mid Atlantic and that whole swath between Upper Mid West and Great Lakes between UPMC and Northwestern cant do diddly-squat with attendings, residents or fellows. Ditto the Bay Area in Cali.Sometimes it is a necessary step.
Most of the time it is the lowest hanging fruit picked by unimaginative and lost “leaders”. Such is the case here. They couldn’t find success with billions in Covid product sales, no way to expense cut their way to success. The board could do some targeted cutting and get us started in the right direction though
Let's spin off the entire sales force and create value!When they spun off animal health, they said it would unlock value. When they spun off Viatris they said it would unlock value. Same with consumer health products. Perhaps we should spin off AB and cronies to unlock value. Or as previous poster said, sell this mess and unlock the value of the brands in companies that know how to operate a pharmaceutical enterprise
